INNATE PHARMA (EPA:IPH) Innate Pharma , announces today the entry in pre-clinical validation of a new drug candidate: IPH 4201, a monoclonal antibody targeting a specific antigen on pancreatic cancer cells
Transparency directive : regulatory news
01/12/2008 18:05
source : webdisclosure.com